Concepedia

Timothy D. Ocain

TD

25

Publications

2K

Citations

20

H-Index

1980

Active since

Affiliations

Millennium Engineering and Integration (United States)(Current)

University of Wisconsin–Madison

Princeton University

Massachusetts General Hospital

AstraZeneca (United States)

Timothy D. Ocain is an author at Millennium Engineering and Integration (United States) specializing in medicine, natural sciences, and biochemistry.

Top concepts

Publications per year

1980–2013

25

Publications

25

NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ

Florian R. Greten, Melek C. Arkan, Julia Bollrath et al. · Cell · 2007 · 605 citations · Full text

, , +9

Substrate-Based Design of the First Class of Angiotensin-Converting Enzyme-Related Carboxypeptidase (ACE2) Inhibitors

Natalie A. Dales, Alexandra E. Gould, James A. Brown et al. · Journal of the American Chemical Society · 2002 · 186 citations · Full text

, , +14

A Selective Small Molecule IκB Kinase β Inhibitor Blocks Nuclear Factor κB-Mediated Inflammatory Responses in Human Fibroblast-Like Synoviocytes, Chondrocytes, and Mast Cells

Danyi Wen, Yuhua Nong, Jennifer G. Morgan et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 112 citations

.alpha.-Keto amide inhibitors of aminopeptidases

Timothy D. Ocain, Daniel H. Rich · Journal of Medicinal Chemistry · 1992 · 97 citations · Full text

Synthesis of (+)-(15,16,19,20,23,24)-hexepi-uvaricin: a bis(tetrahydrofuranyl) annonaceous acetogenin analog

Thomas R. Hoye, Paul R. Hanson, A. C. KOVELESKY et al. · Journal of the American Chemical Society · 1991 · 95 citations

, , +14

Rows per page

1–5 of 25